The global Sexually Transmitted Diseases (STD) Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Sexually Transmitted Diseases (STD) Diagnostics include F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Sexually Transmitted Diseases (STD) Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sexually Transmitted Diseases (STD) Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Diseases (STD) Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexually Transmitted Diseases (STD) Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sexually Transmitted Diseases (STD) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sexually Transmitted Diseases (STD) Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc.
Market Segmentation
By Company
F.Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Hologic Inc.
Creative Diagnostics
Abbott Laboratories
Quest Diagnostics
BD
QIAGEN
Cepheid
bioMerieux Inc.
Segment by Type
Molecular Test
Serologic Test
Point of Care Test
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sexually Transmitted Diseases (STD) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexually Transmitted Diseases (STD) Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1.2.2 Molecular Test 1.2.3 Serologic Test 1.2.4 Point of Care Test 1.2.5 Others 1.3 Market by Application 1.3.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application: 2019 VS 2023 VS 2030 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Perspective (2019-2030) 2.2 Global Sexually Transmitted Diseases (STD) Diagnostics Growth Trends by Region 2.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Region (2019-2024) 2.2.3 Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (2025-2030) 2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Dynamics 2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Industry Trends 2.3.2 Sexually Transmitted Diseases (STD) Diagnostics Market Drivers 2.3.3 Sexually Transmitted Diseases (STD) Diagnostics Market Challenges 2.3.4 Sexually Transmitted Diseases (STD) Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Sexually Transmitted Diseases (STD) Diagnostics by Players 3.1.1 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Players (2019-2024) 3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Players (2019-2024) 3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024 3.4 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio 3.4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2023 3.5 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics Head office and Area Served 3.6 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Product and Application 3.7 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Type 4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Type (2019-2024) 4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (2025-2030) 5 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Application 5.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Application (2019-2024) 5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030) 6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type 6.2.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) 6.2.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2025-2030) 6.2.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type (2019-2030) 6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application 6.3.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) 6.3.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2025-2030) 6.3.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application (2019-2030) 6.4 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country 6.4.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 6.4.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) 6.4.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2025-2030) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030) 7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type 7.2.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) 7.2.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2025-2030) 7.2.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type (2019-2030) 7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application 7.3.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) 7.3.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2025-2030) 7.3.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application (2019-2030) 7.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country 7.4.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 7.4.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) 7.4.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) 7.4.4 Germany 7.4.5 France 7.4.6 U.K. 7.4.7 Italy 7.4.8 Russia 7.4.9 Nordic Countries 8 China 8.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030) 8.2 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type 8.2.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) 8.2.2 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2025-2030) 8.2.3 China Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type (2019-2030) 8.3 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application 8.3.1 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) 8.3.2 China Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2025-2030) 8.3.3 China Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030) 9.2 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type 9.2.1 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) 9.2.2 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2025-2030) 9.2.3 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type (2019-2030) 9.3 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application 9.3.1 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) 9.3.2 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2025-2030) 9.3.3 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application (2019-2030) 9.4 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region 9.4.1 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030 9.4.2 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) 9.4.3 Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2025-2030) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030) 10.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type 10.2.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) 10.2.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2025-2030) 10.2.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type (2019-2030) 10.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application 10.3.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) 10.3.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2025-2030) 10.3.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application (2019-2030) 10.4 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country 10.4.1 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country: 2019 VS 2023 VS 2030 10.4.2 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) 10.4.3 Middle East, Africa, and Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 F.Hoffmann-La Roche Ltd 11.1.1 F.Hoffmann-La Roche Ltd Company Details 11.1.2 F.Hoffmann-La Roche Ltd Business Overview 11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.1.4 F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.1.5 F.Hoffmann-La Roche Ltd Recent Development 11.2 Thermo Fisher Scientific Inc. 11.2.1 Thermo Fisher Scientific Inc. Company Details 11.2.2 Thermo Fisher Scientific Inc. Business Overview 11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.2.4 Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.2.5 Thermo Fisher Scientific Inc. Recent Development 11.3 Hologic Inc. 11.3.1 Hologic Inc. Company Details 11.3.2 Hologic Inc. Business Overview 11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.3.4 Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.3.5 Hologic Inc. Recent Development 11.4 Creative Diagnostics 11.4.1 Creative Diagnostics Company Details 11.4.2 Creative Diagnostics Business Overview 11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.4.4 Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.4.5 Creative Diagnostics Recent Development 11.5 Abbott Laboratories 11.5.1 Abbott Laboratories Company Details 11.5.2 Abbott Laboratories Business Overview 11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.5.4 Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.5.5 Abbott Laboratories Recent Development 11.6 Quest Diagnostics 11.6.1 Quest Diagnostics Company Details 11.6.2 Quest Diagnostics Business Overview 11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.6.4 Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.6.5 Quest Diagnostics Recent Development 11.7 BD 11.7.1 BD Company Details 11.7.2 BD Business Overview 11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.7.4 BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.7.5 BD Recent Development 11.8 QIAGEN 11.8.1 QIAGEN Company Details 11.8.2 QIAGEN Business Overview 11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.8.4 QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.8.5 QIAGEN Recent Development 11.9 Cepheid 11.9.1 Cepheid Company Details 11.9.2 Cepheid Business Overview 11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.9.4 Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.9.5 Cepheid Recent Development 11.10 bioMerieux Inc. 11.10.1 bioMerieux Inc. Company Details 11.10.2 bioMerieux Inc. Business Overview 11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction 11.10.4 bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) 11.10.5 bioMerieux Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.1.1 Research Programs/Design 13.1.1.2 Market Size Estimation 13.1.1.3 Market Breakdown and Data Triangulation 13.1.2 Data Source 13.1.2.1 Secondary Sources 13.1.2.2 Primary Sources 13.2 Author Details 13.3 Disclaimer